期刊文献+

乳腺癌变过程细胞凋亡和增殖变化的研究 被引量:2

Study of Apoptosis and Proliferation in breast tissue Carcinogenesis
下载PDF
导出
摘要 目的探讨乳腺癌变过程细胞凋亡和增殖的变化。方法用末端转移酶介导的脱氧核苷酸末端标记法(TUNEL法)和免疫组化法,检测乳腺癌组31例、乳腺癌前病变组43例(其中乳腺不典型增生21例,乳腺单纯性增生22例),正常乳腺组11例的凋亡指数、增殖细胞核抗原指数和bcl-2蛋白表达强度的变化。结果乳腺癌组凋亡指数和增殖细胞核抗原指数(5.36±0.61和40.84±9.99)低于乳腺癌前病变组(9.97±1.50和48.68±7.78),但高于正常乳腺组的凋亡指数和增殖细胞核抗原指数(2.66±0.49和22.87±6.98),差异有统计学意义(P<0.01);bcl-2蛋白表达分值为2.81±0.88、1.38±0.76、0.50±0.67,以乳腺癌组最高(P<0.01)。对乳腺癌组凋亡指数与PCNA、凋亡指数与bcl-2分值和PCNA与bcl-2分值行等级相关分析,相关系数rs分别为:0.832、-0.608和-0.475。结论乳腺组织细胞凋亡与增殖的异常表达预示着恶性转变可能发生。 Objectives To explore the change of apoptosis and cell proliferation in breast tissue carcinogenesis. Method Using TUNEL and immunohistochemical method , the differences of apoptosis index(AI) and bcl-2 and PCNA index(PI) were examined in 31 case with breast cancer and 43 with its precancerous lesion and 11 with normal tissues. Result The AI and expression of PCNA in breast cancer group were lower than the precancerous lesion(compared 5.36 ± 0.61 to 9.97 ± 1.50, and compared 40. 84±9.99 to 48.68±7.78, P〈0.01) and were higher than the normal group (compare 9.97± 1.50 to 2. 66±0.49, P〈0.01). expression of bcl-2 protein in breast cancer group were the highest than the precancerous lesion and the normal group (compared 2.81±0.88 to 1.38±0.76, and 0.50±0.67, P〈0. 01). There is positive relationship between AI and PI(rs=0. 832, P〈 0.01). There is negative relationships between AI and expression of bcl-2 protein, and between PI and expression of bcl-2 in breast cancer group by degree relative analysis(rs=-0.608 and-0. 475, P〈 0. 01).Conclusion The abnormal expression of apoptosis and cell proliferation in breast tissue indicated that it maybe occurring malignant.
出处 《国际医药卫生导报》 2006年第12期7-9,共3页 International Medicine and Health Guidance News
基金 广东省社会发展领域科技项目(2004-139-47) 吴介平医学科学研究基金资助项目(2003-7-A)
关键词 乳腺癌 细胞凋亡 细胞增殖 BCL-2 Breast tissue cancer Apoptosis Cell proliferation bcl-2
  • 相关文献

参考文献9

二级参考文献20

  • 1左连富,齐风英,刘江惠,郭建文.乳腺癌P53基因蛋白的表达与临床预后的关系[J].癌症,1995,14(4):252-255. 被引量:13
  • 2徐光炜.中国常见恶性肿瘤诊治规范(第八分册).乳腺癌[M].北京医科大学中国协和医科大学联合出版社,1991.53-53.
  • 3Hiyama E,Gollahon L,Kataoka T, et al. Telomerase activity in human breast tumors [J]. Natl Cancer Inst, 1996,88:116- 118.
  • 4Pearson AS, GoUahon L, Neal NC, et al. Detection of telomerase activity in breast masses by fine-needle aspiration [J]. Ann Surg Oncol, 1998,5:186 - 193.
  • 5Yashima K,Milchgrub S,GoUahon L, et al. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma [J]. Clin Cancer Res, 1998,4:229-234.
  • 6Hoos A, Hepp HH, Kaul S, et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer [J]. Clin Cancer Res, 1998,79:8 - 12.
  • 7Clark GM, Osbome CK, Levitt D, et al. Telomerase avtivity and survival of patients with node-positive breast cancer [J].Natl Cancer Inst, 1997,89:1874 - 1881.
  • 8Kim N, Levitt G, Huang F, et al. Correlation of telomerase with prognostic indicators of breast cancer [J]. Proc Annu Meet Am Assoc Cancer Res, 1996,37:A 3852 - 3856.
  • 9Zheng W Q,Anal Quant Cytol Histol,1998年,20卷,1期,1页
  • 10Zhang G J,Anticancer Res,1998年,18卷,3期,1989页

共引文献68

同被引文献26

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部